ScaleReady

GenomeFrontier was awarded a G-Rex® Grant by ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady. The grant supports exploratory studies aimed at enhancing the manufacturing of GF-CART01, our first-in-class, non-viral autologous CAR T cell therapy.